Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Use this SRPT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SRPT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SRPT SEC filings page. Lician reads the product cache first so this HTML stays unique to Sarepta Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full SRPT income, balance, and cash tables.